Process for preparing a polymorph of rosiglitazone maleate

Details for Australian Patent Application No. 2004224068 (hide)

Owner Glaxo Group Limited

Inventors Giles, Robert Gordon; Sasse, Michael John; Ho, Tim Chien Ting; Craig, Andrew Simon

Agent Davies Collison Cave

Pub. Number AU-A-2004224068

PCT Pub. Number WO2004/085435

Priority 0307259.2 28.03.03 GB

Filing date 25 March 2004

Wipo publication date 7 October 2004

International Classifications

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

29 September 2005 PCT application entered the National Phase

  PCT publication WO2004/085435 Priority application(s): WO2004/085435

18 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004224070-Bioreductively-activated prodrugs

2004224062-Secreted protein family